WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2016> 27> 5

Volume: 27 Issue: 5

1. Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011. Page:e45—
2. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer. Page:e46—
3. Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers. Page:e47—
4. Clinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences. Page:e48—
5. Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients. Page:e49—
6. The 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10-13, 2016, Guangzhou. Page:e50—
7. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. Page:e51—
8. Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer. Page:e52—
9. Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia. Page:e54—

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.